The latest price target for Encompass Health (NYSE:EHC) was reported by Truist Securities on August 15, 2024. The analyst firm set a price target for $104.00 expecting EHC to rise to within 12 months (a possible 12.25% upside). 19 analyst firms have reported ratings in the last year.

The latest analyst rating for Encompass Health (NYSE:EHC) was provided by Truist Securities, and Encompass Health maintained their buy rating.

There is no last upgrade for Encompass Health

There is no last downgrade for Encompass Health.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Encompass Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Encompass Health was filed on August 15, 2024 so you should expect the next rating to be made available sometime around August 15, 2025.

While ratings are subjective and will change, the latest Encompass Health (EHC) rating was a maintained with a price target of $100.00 to $104.00. The current price Encompass Health (EHC) is trading at is $92.65, which is out of the analyst’s predicted range.